How Much Does Therapeutic Inertia in Type 2 Diabetes Cost the UK? A Modeling Evaluation of Economic Burden

May-20

Endocrinology Healthcare Cost Pharmacoepidemiology

AUTHORS : Prof Steve Bain, Swansea University Medical School, Office – 123 , Ground Floor, Grove Building, Singleton Campus, Swansea SA2 8PP Wales, UK – Email: s.c.bain@swansea.ac.uk – Profile: https://www.swansea.ac.uk/staff/medicine/research/bain-s-c/ – Cannot find details for Laura Rizkallah, Novo Nordisk

JOURNAL : Value in Health

REFERENCE: 23(S1):S115

DOI : 10.1016/j.jval.2020.04.228

How Much Does Therapeutic Inertia in Type 2 Diabetes Cost the UK? A Modeling Evaluation of Economic Burden

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease